Vascular Changes in Eyes Treated with Dexamethasone Intravitreal Implant for Macular Edema after Retinal Vein Occlusion – Corrected Proof

Objective: To evaluate the angiographic findings in eyes from 2 clinical trials of the dexamethasone intravitreal implant (DEX implant) 0.7 mg in the treatment of macular edema (ME) after branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). Design: Post hoc analysis of pooled data from 2 identical phase 3 clinical trials. Participants: Patients with vision loss as a result of ME (≥6 weeks' duration) after BRVO or CRVO for whom angiographic data were available (n = 329 eyes). Methods: Fluorescein angiography (FA) results assessed by masked, certified graders using standardized grading protocols. Main Outcome Measures: The primary (Read more...)

Full Story →